ACE2 and COVID-19: Since ACE2, which is a part of RAAS and the entry point of SARs-CoV-2 in the cell, Sartans bearing anionic groups, tetrazolate, and carboxylate, were investigated as possible antivirals for the treatment of COVID-19, either by blocking entry or replication of the virus [13,22,23].